Sean Brynjelsen - 12 Jul 2022 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
Chief Executive Officer
Signature
/s/ Sean E. Brynjelsen
Issuer symbol
ETON
Transactions as of
12 Jul 2022
Net transactions value
$0
Form type
4
Filing time
18 Jul 2022, 16:36:12 UTC
Previous filing
28 Feb 2022
Next filing
23 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETON Restricted Stock Units Award $0 +110,000 $0.000000 110,000 12 Jul 2022 Common Stock 110,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
F2 The restricted stock units vest in four equal annual installments beginning July 12, 2023, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.